Carrier-Mediated Delivery of 9-(2-Phosphonylmethoxyethyl)Adenine to Parenchymal Liver Cells: a Novel Therapeutic Approach for Hepatitis B

Our aim is to selectively deliver 9-(2-phosphonylmethoxyethyl)adenine (PMEA) to parenchymal liver cells, the primary site of hepatitis B virus (HBV) infection. Selective delivery is necessary because PMEA, which is effective against HBV in vitro, is hardly taken up by the liver in vivo. Lactosylated...

Popoln opis

Bibliografske podrobnosti

izdano v:	Antimicrob Agents Chemother
Principais autores:	de Vrueh, Remco L. A., Rump, Erik T., van de Bilt, Erika, van Veghel, Richard, Balzarini, Jan, Biessen, Erik A. L., van Berkel, Theo J. C., Bijsterbosch, Martin K.
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 2000
Teme:	Pharmacology
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89714/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10681306/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.3.477-483.2000
Oznake:	Označite Brez oznak, prvi označite!